Cite
Artesunate enhances γδ T-cell-mediated antitumor activity through augmenting γδ T-cell function and reversing immune escape of HepG2 cells.
MLA
Qian, Peng, et al. “Artesunate Enhances Γδ T-Cell-Mediated Antitumor Activity through Augmenting Γδ T-Cell Function and Reversing Immune Escape of HepG2 Cells.” Immunopharmacology & Immunotoxicology, vol. 40, no. 2, Apr. 2018, pp. 107–16. EBSCOhost, https://doi.org/10.1080/08923973.2017.1386212.
APA
Qian, P., Zhang, Y.-W., Zhou, Z.-H., Liu, J.-Q., Yue, S.-Y., Guo, X.-L., Sun, L.-Q., Lv, X.-T., & Chen, J.-Q. (2018). Artesunate enhances γδ T-cell-mediated antitumor activity through augmenting γδ T-cell function and reversing immune escape of HepG2 cells. Immunopharmacology & Immunotoxicology, 40(2), 107–116. https://doi.org/10.1080/08923973.2017.1386212
Chicago
Qian, Peng, Yong-Wen Zhang, Zhong-Hai Zhou, Jun-Quan Liu, Su-Yang Yue, Xiang-Li Guo, Lei-Qing Sun, Xiao-Ting Lv, and Jian-Qun Chen. 2018. “Artesunate Enhances Γδ T-Cell-Mediated Antitumor Activity through Augmenting Γδ T-Cell Function and Reversing Immune Escape of HepG2 Cells.” Immunopharmacology & Immunotoxicology 40 (2): 107–16. doi:10.1080/08923973.2017.1386212.